Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleAlnylam and Tekmira Participate in New Research Collaboration Aug 06, 2009 Alnylam and Tekmira Participate in New Research Collaboration 21.8 KB – New Collaboration Focused on Discovery of Novel Cationic Lipids for Systemic Delivery of RNAi Therapeutics – ... Read more Summary ToggleTekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial Jul 02, 2009 Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial 18.1 KB ... Read more Summary ToggleTekmira Pharmaceuticals Presents ApoB SNALP and PLK1 SNALP Data at Leading Scientific Conference May 28, 2009 Tekmira Pharmaceuticals Presents ApoB SNALP and PLK1 SNALP Data at Leading Scientific Conference 19.5 KB ApoB SNALP Duration of Response Greater than 1 Month in Non-Human Primates ... Read more Summary ToggleTekmira Pharmaceuticals Corporation Announces First Quarter 2009 Operating Results and Provides Corporate Update May 13, 2009 Tekmira Pharmaceuticals Corporation Announces First Quarter 2009 Operating Results and Provides Corporate Update 26.5 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory - First Quarter 2009 Operating Results and Corporate Update May 11, 2009 Tekmira Pharmaceuticals Conference Call Advisory - First Quarter 2009 Operating Results and Corporate Update 12.9 KB ... Read more Summary ToggleRoche Partners with Tekmira Pharmaceuticals to Advance RNAi Product Candidates May 11, 2009 Roche Partners with Tekmira Pharmaceuticals to Advance RNAi Product Candidates 12.9 KB ... Read more Summary ToggleTekmira Pharmaceuticals Receives Clearance from FDA to Initiate ApoB SNALP Phase 1 Clinical Trial May 07, 2009 Tekmira Pharmaceuticals Receives Clearance from FDA to Initiate ApoB SNALP Phase 1 Clinical Trial 18 KB ... Read more Summary ToggleTekmira Pharmaceuticals Files IND for ApoB SNALP Apr 14, 2009 Tekmira Pharmaceuticals Files IND for ApoB SNALP 17.2 KB ... Read more Summary ToggleTekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients with Liver Cancer. First Clinical Trial Utilizing SNALP Triggers Milestone Payment Apr 03, 2009 Tekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients with Liver Cancer. First Clinical Trial Utilizing SNALP Triggers Milestone Payment 18.5 KB ... Read more Summary ToggleTekmira Pharmaceuticals Extends Research Collaboration with Bristol-Myers Squibb through 2009 Mar 25, 2009 Tekmira Pharmaceuticals Extends Research Collaboration with Bristol-Myers Squibb through 2009 17.2 KB ... Read more Pagination First page First Previous page Previous … Page 46 Current page 47 Page 48 Page 49 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleAlnylam and Tekmira Participate in New Research Collaboration Aug 06, 2009 Alnylam and Tekmira Participate in New Research Collaboration 21.8 KB – New Collaboration Focused on Discovery of Novel Cationic Lipids for Systemic Delivery of RNAi Therapeutics – ... Read more Summary ToggleTekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial Jul 02, 2009 Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial 18.1 KB ... Read more Summary ToggleTekmira Pharmaceuticals Presents ApoB SNALP and PLK1 SNALP Data at Leading Scientific Conference May 28, 2009 Tekmira Pharmaceuticals Presents ApoB SNALP and PLK1 SNALP Data at Leading Scientific Conference 19.5 KB ApoB SNALP Duration of Response Greater than 1 Month in Non-Human Primates ... Read more Summary ToggleTekmira Pharmaceuticals Corporation Announces First Quarter 2009 Operating Results and Provides Corporate Update May 13, 2009 Tekmira Pharmaceuticals Corporation Announces First Quarter 2009 Operating Results and Provides Corporate Update 26.5 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory - First Quarter 2009 Operating Results and Corporate Update May 11, 2009 Tekmira Pharmaceuticals Conference Call Advisory - First Quarter 2009 Operating Results and Corporate Update 12.9 KB ... Read more Summary ToggleRoche Partners with Tekmira Pharmaceuticals to Advance RNAi Product Candidates May 11, 2009 Roche Partners with Tekmira Pharmaceuticals to Advance RNAi Product Candidates 12.9 KB ... Read more Summary ToggleTekmira Pharmaceuticals Receives Clearance from FDA to Initiate ApoB SNALP Phase 1 Clinical Trial May 07, 2009 Tekmira Pharmaceuticals Receives Clearance from FDA to Initiate ApoB SNALP Phase 1 Clinical Trial 18 KB ... Read more Summary ToggleTekmira Pharmaceuticals Files IND for ApoB SNALP Apr 14, 2009 Tekmira Pharmaceuticals Files IND for ApoB SNALP 17.2 KB ... Read more Summary ToggleTekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients with Liver Cancer. First Clinical Trial Utilizing SNALP Triggers Milestone Payment Apr 03, 2009 Tekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients with Liver Cancer. First Clinical Trial Utilizing SNALP Triggers Milestone Payment 18.5 KB ... Read more Summary ToggleTekmira Pharmaceuticals Extends Research Collaboration with Bristol-Myers Squibb through 2009 Mar 25, 2009 Tekmira Pharmaceuticals Extends Research Collaboration with Bristol-Myers Squibb through 2009 17.2 KB ... Read more Pagination First page First Previous page Previous … Page 46 Current page 47 Page 48 Page 49 … Next page Next Last page Last
Tekmira Pharmaceuticals Presents ApoB SNALP and PLK1 SNALP Data at Leading Scientific Conference 19.5 KB
Tekmira Pharmaceuticals Corporation Announces First Quarter 2009 Operating Results and Provides Corporate Update 26.5 KB
Tekmira Pharmaceuticals Conference Call Advisory - First Quarter 2009 Operating Results and Corporate Update 12.9 KB
Tekmira Pharmaceuticals Receives Clearance from FDA to Initiate ApoB SNALP Phase 1 Clinical Trial 18 KB
Tekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients with Liver Cancer. First Clinical Trial Utilizing SNALP Triggers Milestone Payment 18.5 KB
Tekmira Pharmaceuticals Extends Research Collaboration with Bristol-Myers Squibb through 2009 17.2 KB